Velarion · Company Intelligence
Compensation Brief
Fiscal year 2025 · Filings through 2026-10-13

Zoetis Inc. (ZTS)

CEO Kristin Peck was paid $19,046,509 in fiscal year 2025, ↑ up 10.7% from fiscal year 2024, the 38th percentile of its disclosed peer group (SEC filing 0001555280-26-000015 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.

$19,046,509 ↑
Kristin Peck total, FY2025
38th
CEO pay percentile vs peers
236:1
CEO-to-median pay ratio
85.57%
Say-on-pay support, latest vote

Track this company's pay every filing: join the Pro seat waitlist

Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year

A confirmation now and one email when Pro opens, and nothing else. Privacy

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Kristin Peck (Chief Executive Officer), FY2025 total compensation $19,046,509 (base salary $1,350,000) [exec_comp, SEC accession 0001555280-26-000015, filed 2026-04-08]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

ZTS's next annual pay disclosure, estimated April 7, 2027.est. Filing ↗

Page 2 of 36 of the Zoetis Inc. Executive Compensation Report, as it is delivered: Executive Summary.

That is page 2 of 36 of the full Executive Compensation Report, shown as it is delivered. The rest:

  1. Summary Compensation Table
  2. Equity transactions since the proxy statement
  3. Grants of plan-based awards
  4. Outstanding equity awards at fiscal year-end
  5. Incentive-plan design (CD&A)
  6. Say-on-pay
  7. CEO pay ratio
  8. Director compensation
  9. Board fee structure and ownership guideline
  10. Disclosed peer group
  11. Source register

Every figure above cites the filing it came from (accession 0001555280-26-000015, filed 2026-10-13) — see the source register, §11.

01

Summary Compensation Table — fiscal year 2025

Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
Kristin Peck$1,350,000—$10,218,583$3,406,229$2,187,000$0$1,884,697$19,046,509
Chief Executive Officer
Wetteny Joseph800,000—2,849,611949,961832,0000164,9415,596,513
Executive Vice President and Chief Financial Officer
Jamie Brannan720,000—1,673,899557,994673,9200348,5283,974,341
EVP and Chief Commercial Officer
Robert Polzer710,000—1,666,255555,461590,7200144,7213,667,157
Former EVP and President, Research and Development
Roxanne Lagano700,000—1,042,198347,495604,8000130,7872,825,280
EVP, General Counsel and Corporate Secretary

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2025 totalFY2024 totalFY2023 totalΔ FY2024→2025
Kristin Peck$19,046,509$17,206,760$15,237,853↑ +1,839,749
Wetteny Joseph5,596,5135,089,4614,247,772↑ +507,052
Jamie Brannan3,974,3413,024,611—↑ +949,730
Robert Polzer3,667,1572,973,0382,440,473↑ +694,119
Roxanne Lagano2,825,2802,615,155—↑ +210,125

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

You have just read Zoetis Inc.'s Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper ZTS reports.

We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.

Get the Zoetis Inc. Peer Teardown Report

$19,046,509 Kristin Peck total, FY2025

$199

The free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.

Data as of October 13, 2026 · Source: 0001555280-26-000015 · Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Reports for ZTS

Every report below is generated from the same filings as the free brief above, at the moment of purchase. What each one adds:

Executive Compensation ReportThe free page is the headline figures. The report is every award, peer and vote combined into one document you can hand to a committee.$1,500 →Reverse Peer AnalysisThe free page is the one line. The analysis reads every company that names this one in its own peer group.$299 →Peer Teardown ReportThe free page is the headline. The teardown reads every company in the disclosed peer group on its own numbers.$199 →
ZTSon Velarion Intel, free → The platform reading of this company, beside the same data as a subscription.

Order ZTS

Pick the report, add the email the receipt and the PDF go to, and pay by card on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

How we handle your data → Privacy

Companies that benchmark against ZTS
9 companies name ZTS as a compensation peer

Each company listed discloses ZTS in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ZTS in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.

Get the Zoetis Inc. Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
01b

Executives — the named officers

One page per officer: the same table above, read for one person at a time — his own figure and every fiscal year the register holds.

ExecutiveRoleFY2025 total
Jamie BrannanCCO$3,974,341
Kristin PeckCEO$19,046,509
Robert PolzerExecutive$3,667,157
Roxanne LaganoGeneral Counsel$2,825,280
Wetteny JosephCFO$5,596,513
01c

Board of directors

One page per director: the seat, the committees and the fee table, read for one person at a time.

DirectorRoleFY2025 total
Antoinette R. LeatherberryIndependent Director$355,000
Frank A. D'AmelioIndependent Director$375,000
Gavin D.K. HattersleyIndependent Director$356,250
Gregory NordenIndependent Director$375,000
Louise M. ParentIndependent Director$373,750
Mark StetterIndependent Director$316,667
Michael B. McCallisterChair of the Board$500,000
Paul M. BisaroIndependent Director$350,000
Robert W. ScullyFormer director (through FY2025)$300,000
Sanjay KhoslaIndependent Director$350,000
Stephanie TileniusIndependent Director$258,333
Vanessa BroadhurstIndependent Director$355,000
Willie M. ReedIndependent Director$375,000
02

Equity transactions since the proxy statement was filed

Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Wetteny JosephChief Financial Officer2026-04-10A873.95$40$34,643Derivative, Class A CommonForm 4 ↗
Dividend-equivalent accruals2026-04-10—263—~10,4394 insiders, 4 accrual rows
Roxanne LaganoExecutive Vice President2026-04-10A550.644021,828Derivative, Class A CommonForm 4 ↗
Kristin C. PeckDirector2026-04-10A2,776.7740110,071Derivative, Class A CommonForm 4 ↗
Julie FullerExecutive Vice President2026-04-10A550.644021,828Derivative, Class A CommonForm 4 ↗
Kevin EschExecutive Vice President2026-04-30D751158,623CommonForm 4 ↗
Kevin EschExecutive Vice President2026-04-30D259.92——Derivative, Class A CommonForm 4 ↗
Kevin EschExecutive Vice President2026-04-30A259——CommonForm 4 ↗
Michael B. McCallisterDirector2026-05-11A3,00078233,273CommonForm 4 ↗
Frank A. DamelioDirector2026-05-13A6,65075501,344CommonForm 4 ↗
Paul M. BisaroDirector2026-05-13A2,00076151,750CommonForm 4 ↗
Louise M. ParentDirector2026-05-20D10,186.6700Derivative, Class A CommonForm 4 ↗
Dividend-equivalent accruals2026-05-20—1,944——1 insider, 1 accrual row
Louise M. ParentDirector2026-05-20A10,186——CommonForm 4 ↗
Louise M. ParentDirector2026-05-20A1,944——CommonForm 4 ↗
Mark StetterDirector2026-05-21D1,572.06——Derivative, Class A CommonForm 4 ↗
Mark StetterDirector2026-05-21A1,572——CommonForm 4 ↗
Michael B. McCallisterDirector2026-06-10D1,20900CommonForm 4 ↗
Mark StetterDirector2026-06-18A317.627925,000Derivative, Class A CommonForm 4 ↗
Dividend-equivalent accruals2026-07-10—2,058—~53,9508 insiders, 8 accrual rows
Kristin C. PeckDirector2026-07-10A616.092616,154Derivative, Class A CommonForm 4 ↗
Frank A. DamelioDirector2026-08-07D6,65000CommonForm 4 ↗
James SaccaroEVP, CFO & COO2026-08-31A81,06300Derivative, Class A CommonForm 4 ↗
Mark StetterDirector2026-09-17A342.377325,000Derivative, Class A CommonForm 4 ↗
Julie FullerExecutive Vice President2026-09-30D799.07——Derivative, Class A CommonForm 4 ↗
Julie FullerExecutive Vice President2026-09-30D2747019,133CommonForm 4 ↗
Julie FullerExecutive Vice President2026-09-30A799——CommonForm 4 ↗
Dividend-equivalent accruals2026-10-09—2,051—~53,6857 insiders, 7 accrual rows
Kristin C. PeckDirector2026-10-09A720.142618,846Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

View all 45 transactions
InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Wetteny JosephChief Financial Officer2026-04-10A873.95$40$34,643Derivative, Class A CommonForm 4 ↗
Kevin EschExecutive Vice President2026-04-10A1.394055Derivative, Class A CommonForm 4 ↗
Keith SarbaughExecutive Vice President2026-04-10A230.76409,147Derivative, Class A CommonForm 4 ↗
Rimma DriscollExecutive Vice President2026-04-10A26.2401,038Derivative, Class A CommonForm 4 ↗
Astorga Jeannette FerranExecutive Vice President2026-04-10A540198Derivative, Class A CommonForm 4 ↗
Roxanne LaganoExecutive Vice President2026-04-10A550.644021,828Derivative, Class A CommonForm 4 ↗
Kristin C. PeckDirector2026-04-10A2,776.7740110,071Derivative, Class A CommonForm 4 ↗
Julie FullerExecutive Vice President2026-04-10A550.644021,828Derivative, Class A CommonForm 4 ↗
Kevin EschExecutive Vice President2026-04-30D751158,623CommonForm 4 ↗
Kevin EschExecutive Vice President2026-04-30D259.92——Derivative, Class A CommonForm 4 ↗
Kevin EschExecutive Vice President2026-04-30A259——CommonForm 4 ↗
Michael B. McCallisterDirector2026-05-11A3,00078233,273CommonForm 4 ↗
Frank A. DamelioDirector2026-05-13A6,65075501,344CommonForm 4 ↗
Paul M. BisaroDirector2026-05-13A2,00076151,750CommonForm 4 ↗
Louise M. ParentDirector2026-05-20D10,186.6700Derivative, Class A CommonForm 4 ↗
Louise M. ParentDirector2026-05-20D1,944.3600Derivative, Class A CommonForm 4 ↗
Louise M. ParentDirector2026-05-20A10,186——CommonForm 4 ↗
Louise M. ParentDirector2026-05-20A1,944——CommonForm 4 ↗
Mark StetterDirector2026-05-21D1,572.06——Derivative, Class A CommonForm 4 ↗
Mark StetterDirector2026-05-21A1,572——CommonForm 4 ↗
Michael B. McCallisterDirector2026-06-10D1,20900CommonForm 4 ↗
Mark StetterDirector2026-06-18A317.627925,000Derivative, Class A CommonForm 4 ↗
Wetteny JosephChief Financial Officer2026-07-10A363.05269,519Derivative, Class A CommonForm 4 ↗
Roxanne LaganoExecutive Vice President2026-07-10A314.65268,250Derivative, Class A CommonForm 4 ↗
Keith SarbaughExecutive Vice President2026-07-10A259.64266,808Derivative, Class A CommonForm 4 ↗
Astorga Jeannette FerranExecutive Vice President2026-07-10A45.33261,188Derivative, Class A CommonForm 4 ↗
Julie FullerExecutive Vice President2026-07-10A314.65268,250Derivative, Class A CommonForm 4 ↗
Rimma DriscollExecutive Vice President2026-07-10A237.64266,231Derivative, Class A CommonForm 4 ↗
Kevin EschExecutive Vice President2026-07-10A308.05268,077Derivative, Class A CommonForm 4 ↗
Abhay U. NayakExecutive Vice President2026-07-10A214.62265,627Derivative, Class A CommonForm 4 ↗
Kristin C. PeckDirector2026-07-10A616.092616,154Derivative, Class A CommonForm 4 ↗
Frank A. DamelioDirector2026-08-07D6,65000CommonForm 4 ↗
James SaccaroEVP, CFO & COO2026-08-31A81,06300Derivative, Class A CommonForm 4 ↗
Mark StetterDirector2026-09-17A342.377325,000Derivative, Class A CommonForm 4 ↗
Julie FullerExecutive Vice President2026-09-30D799.07——Derivative, Class A CommonForm 4 ↗
Julie FullerExecutive Vice President2026-09-30D2747019,133CommonForm 4 ↗
Julie FullerExecutive Vice President2026-09-30A799——CommonForm 4 ↗
Roxanne LaganoExecutive Vice President2026-10-09A367.79269,625Derivative, Class A CommonForm 4 ↗
Kristin C. PeckDirector2026-10-09A720.142618,846Derivative, Class A CommonForm 4 ↗
Kevin EschExecutive Vice President2026-10-09A360.07269,423Derivative, Class A CommonForm 4 ↗
Rimma DriscollExecutive Vice President2026-10-09A277.77267,269Derivative, Class A CommonForm 4 ↗
Julie FullerExecutive Vice President2026-10-09A367.79269,625Derivative, Class A CommonForm 4 ↗
Keith SarbaughExecutive Vice President2026-10-09A303.49267,942Derivative, Class A CommonForm 4 ↗
Astorga Jeannette FerranExecutive Vice President2026-10-09A52.98261,387Derivative, Class A CommonForm 4 ↗
Abhay U. NayakExecutive Vice President2026-10-09A321.49268,414Derivative, Class A CommonForm 4 ↗
03

Grants of plan-based awards — fiscal year 2025

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
Wetteny JosephPSU2025-02-195,54811,096—22,192$1,899,746
Wetteny JosephRSU2025-02-19——6,064—949,865
Kristin PeckPSU2025-02-1919,89539,790—79,5806,812,446
Jamie BrannanPSU2025-02-193,2596,518—13,0361,115,947
Jamie BrannanOPTION2025-02-19——13,877—557,994
Jamie BrannanRSU2025-02-19——3,562—557,952
Wetteny JosephOPTION2025-02-19——23,625—949,961
Roxanne LaganoRSU2025-02-19——2,218—347,428
Kristin PeckOPTION2025-02-19——84,711—3,406,229
Robert PolzerOPTION2025-02-19——13,814—555,461
Robert PolzerRSU2025-02-19——3,546—555,445
Robert PolzerPSU2025-02-193,2446,488—12,9761,110,810
Roxanne LaganoPSU2025-02-192,0294,058—8,116694,770
Kristin PeckRSU2025-02-19——21,745—3,406,137
Roxanne LaganoOPTION2025-02-19——8,642—347,495
03b

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
Wetteny Joseph$949,865$1,899,746$949,96150.0%
Kristin Peck3,406,1376,812,4463,406,22950.0%
Jamie Brannan557,9521,115,947557,99450.0%
Roxanne Lagano347,428694,770347,49550.0%
Robert Polzer555,4451,110,810555,46150.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

04

Outstanding equity awards at fiscal year-end 2025

ExecutiveAwardShares unvestedExercise priceMarket value unvested
Robert PolzerPSU6,554—$824,624
Wetteny JosephRSU2,765—347,892
Robert PolzerPSU2,755—346,634
Robert PolzerRSU670—84,299
Kristin PeckOption41,666196.14—
Roxanne LaganoRSU603—75,869
Wetteny JosephOption23,625156.64—
Roxanne LaganoPSU4,100—515,862
Kristin PeckRSU11,064—1,392,072
Robert PolzerRSU3,582—450,687
Jamie BrannanPSU2,308—290,393
Wetteny JosephRSU1,403—176,525
Jamie BrannanRSU1,054—132,614
Jamie BrannanRSU379—47,686
Kristin PeckOption84,711156.64—
Roxanne LaganoOption2,181162.07—
Kristin PeckPSU40,198—5,057,712
Wetteny JosephOption10,416196.14—
Kristin PeckRSU6,198—779,832
Jamie BrannanOption13,877156.64—
Robert PolzerRSU1,258—158,282
Wetteny JosephPSU11,210—1,410,442
Kristin PeckRSU21,968—2,764,014
Roxanne LaganoRSU1,085—136,515
Kristin PeckOption22,383162.07—
Wetteny JosephOption5,069162.07—
Jamie BrannanOption3,970196.14—
Robert PolzerOption4,738196.14—
Robert PolzerOption2,420162.07—
Robert PolzerOption13,814156.64—
Roxanne LaganoOption8,642156.64—
Jamie BrannanPSU6,584—828,399
Kristin PeckPSU24,227—3,048,241
Jamie BrannanRSU3,599—452,826
Wetteny JosephRSU6,126—770,773
Wetteny JosephPSU6,057—762,092
Roxanne LaganoPSU2,374—298,697
Roxanne LaganoRSU2,241—281,963
Kristin PeckOption54,751201.3—
Jamie BrannanOption1,368162.07—
Roxanne LaganoOption4,084196.14—
05

Incentive-plan design — the Compensation Discussion & Analysis

Foster a pay-for-performance culture by tying a large portion of our executives pay to performance against pre-established annual Company financial and operational metrics, as well as pre-established annual individual goals for each executive. Align the interests of management with results delivered to our shareholders through the use of long-term incentive programs that are designed to reward executives for increasing the value of our shareholders investment. Provide competitive compensation opportunities over the short term (base salary and annual incentives) and long term (equity-based long-term incentive awards) which are intended to retain our experienced management team, enable us to attract new qualified executives when needed and remain externally aligned with the compensation practices of our peer group, with the majority of pay at-risk tied to long-term performance.

CEO STI target (% of salary)150%
CEO LTI target (% of salary)—
Independent consultantPearl Meyer
Clawback policyTrue
Anti-hedgingTrue
Anti-pledgingTrue
06

Say-on-pay — recent advisory votes

Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20262026-05-20306,328,99251,638,692602,52985.57%Passed
20252025-05-21334,181,20235,190,5642,702,89190.47%Passed
20242024-05-22351,133,25934,984,587596,90390.94%Passed
20232023-05-18374,449,89927,107,764706,03393.25%Passed
20222022-05-19374,661,27826,395,514632,12893.42%Passed
20212021-05-20366,731,85531,638,037649,33592.06%Passed

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.

Say-on-pay — history, company's computation

Meeting yearMeeting dateApproval — company's computation
20262026-05-2085.57%a
20252025-05-2190.47%b
20242024-05-2290.94%c

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

c. Approved under the standard stated in the filing — “Abstentions and broker non-votes will have no effect on the outcome of the vote.”.

Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

07

CEO pay ratio

Ratio (CEO : median employee)236 : 1
CEO total compensation$19,046,509
Median employee compensation$80,592
08

Director compensation — fiscal year 2025

DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Michael B. McCallisterIndependent · Board Chair$250,000$250,000$0$0$0$500,000
Frank A. D'AmelioIndependent · Audit · Human Resources (Chair)125,000250,000000375,000
Gregory NordenIndependent · Audit (Chair) · Corporate Governance125,000250,000000375,000
Willie M. ReedIndependent · Corporate Governance · Quality and Innovation (Chair)125,000250,000000375,000
Louise M. ParentIndependent · Audit · Corporate Governance · Not standing for re-election118,750250,000005,000373,750
Gavin D.K. HattersleyIndependent · Audit · Corporate Governance (Chair)106,250250,000000356,250
Vanessa BroadhurstIndependent · Corporate Governance · Quality and Innovation100,000250,000005,000355,000
Antoinette R. LeatherberryIndependent · Audit · Human Resources100,000250,000005,000355,000
Paul M. BisaroIndependent · Corporate Governance · Quality and Innovation100,000250,000000350,000
Sanjay KhoslaIndependent · Human Resources · Quality and Innovation100,000250,000000350,000
Mark StetterIndependent · Human Resources · Quality and Innovation · Newly elected66,667250,000000316,667
Robert W. ScullyIndependent · Departed during FY50,000250,000000300,000
Stephanie TileniusIndependent · Audit · Human Resources · Newly elected8,333250,000000258,333
Kristin C. PeckEmployee director000—00
09

Board fee structure and ownership guideline

Annual cash retainer$100,000
Annual equity retainer$250,000
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)25,000 / 6,250
Stock ownership guideline$500,000
09b

Total cost of the board

ComponentFY2025
Cash retainers and fees$1,375,000
Equity awards (grant-date value)$3,250,000
All other compensation$15,000
Total cost of the board$4,640,000

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

10

Disclosed peer group — fiscal year 2025

The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.

10a

Peer reciprocity

Of the companies Zoetis Inc. names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.

Reciprocity shown where the peer's own current proxy has been read — each mark is cited in the register to that peer's filing. A dash means the peer's current proxy was read and names no reciprocal group including Zoetis Inc..

10b

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Thermo Fisher Scientific Inc.2025Marc Casper$1,785,534$65,730,211$7,951,377$3,742,123$79,923,350
2Baxter International Inc.2025Andrew Hider499,31523,133,5183,185,053820,12529,805,182
3Gilead Sciences, Inc2025Daniel O'Day1,795,19215,238,4024,500,0604,848,12028,437,198
4IQVIA Holdings Inc.2025Ari Bousbib1,800,00015,749,9574,528,3174,966,12728,128,245
5Biogen Inc.2025Christopher Viehbacher1,727,88518,368,87503,190,87523,646,004
6Boston Scientific Corporation2025Michael Mahoney1,442,60313,608,0563,749,9804,002,00123,532,050
7Bristol-Myers Squibb Company2025Christopher Boerner1,586,34616,061,39903,754,68421,879,919
8Stryker Corporation2025Kevin Lobo1,500,0009,764,1366,920,7812,250,00021,401,495
9Vertex Pharmaceuticals2025Reshma Kewalramani1,600,00015,002,27004,118,64021,144,261
10Intuitive Surgical Inc.2025David Rosa858,75018,674,87201,373,85920,997,480
11Zoetis Inc.2025Kristin Peck1,350,00010,218,5833,406,2292,187,00019,046,509
12Edward Lifesciences Corporation2025Bernard Zovighian1,192,5007,167,0246,499,1092,406,53717,454,255
13Becton, Dickinson and Company2025Thomas Polen1,395,4639,991,8543,311,8611,852,01017,129,140
14Zimmer Biomet Holdings, Inc.2025Ivan Tornos1,281,84612,000,10102,420,76716,106,550
15Elanco Animal Health Incorporated2025Jeffrey Simmons1,200,0009,000,0003,000,0041,700,40014,925,756
16IDEXX Laboratories, Inc.2025Jonathan Mazelsky1,150,0005,399,8815,400,0012,593,00014,580,122
17Agilent Technologies, Inc.2025Padraig McDonnell1,141,3458,169,8502,017,7591,436,80912,827,236

Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

10c

Incentive design against the same peers

CompanyAnnual incentive payoutLong-term vehicle mixPSU measures include TSRCompensation consultant
Zoetis Inc.108%PSU 50 · Options 25 · RSU 25Yes — Relative TSRPearl Meyer
Agilent Technologies, Inc.not disclosedPSU 60 · Options 20 · RSU 20NoSemler Brossy
Baxter International Inc.not disclosednot disclosedNoAon Consulting, Inc. (Aon)
Becton, Dickinson and Company85%PSU 50 · Options 25 · RSU 25NoSemler Brossy
Biogen Inc.127%PSU 60 · RSU 40YesPay Governance
Boston Scientific Corporation173%PSU 50 · RSU 25 · Options 25NoSemler Brossy Consulting Group, LLC
Bristol-Myers Squibb Company157.66%PSU 60 · MSU 40Yes — 3-Year Relative TSR CAGRFarient Advisors LLC
Edward Lifesciences Corporation127%Options 50 · PSU 25 · RSU 25NoSemler Brossy Consulting Group
Elanco Animal Health Incorporatednot disclosednot disclosedNoWillis Towers Watson
Gilead Sciences, Inc180%PSU 50 · Options 25 · RSU 25Yes — Relative TSRFW Cook
IDEXX Laboratories, Inc.140%Options 50 · PSU 50NoFarient
Intuitive Surgical Inc.115.2%RSU 50 · PSU 50NoAon
IQVIA Holdings Inc.not disclosedPSU 75 · Options 25YesMeridian Compensation Partners, LLC
Stryker Corporation100%PSU 48 · Options 34NoSemler Brossy
Thermo Fisher Scientific Inc.99.8%PSU 50 · Options 50Yes — Relative TSRPearl Meyer
Vertex Pharmaceuticalsnot disclosedPSU 55 · RSU 45Nonot disclosed
Zimmer Biomet Holdings, Inc.125.9%RSU 50 · PSU 50Yes — Relative TSRSemler Brossy

Read from each company's Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company's filing does not state the item.

10d

Frequently asked questions

Who was the highest-paid executive at Zoetis Inc. in fiscal 2025?
As disclosed, Kristin Peck (Chief Executive Officer) was the highest-paid executive at Zoetis Inc. in fiscal 2025, with total compensation of $19,046,509.
How does Zoetis Inc.'s chief executive pay compare to its disclosed peer group?
As disclosed, Kristin Peck's total compensation ranked at the 38th percentile of Zoetis Inc.'s disclosed peer group.
What is Zoetis Inc.'s CEO-to-median employee pay ratio?
As disclosed, Zoetis Inc.'s CEO-to-median employee pay ratio was 236:1.
How did shareholders vote on Zoetis Inc.'s executive compensation?
As disclosed, 85.57% of shareholders supported Zoetis Inc.'s executive compensation in the latest say-on-pay vote.
How much does Zoetis Inc. spend in total on board compensation for fiscal 2025?
As disclosed, Zoetis Inc. reported total board compensation of $4,640,000 for fiscal 2025.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

11

Source register

Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.

#SupportsDocumentFiledAccessionLocation in document
1Section 01, Kristin PeckDEF 14A2026-04-080001555280-26-000015Section “Summary Compensation Table”. As printed: 19,046,509. Filing ↗machine: r3 · c24 · span 1448788–1448798
2Section 01, Wetteny JosephDEF 14A2026-04-080001555280-26-000015Section “Summary Compensation Table”. As printed: 5,596,513. Filing ↗machine: r6 · c24 · span 1457417–1457426
3Section 01, Jamie BrannanDEF 14A2026-04-080001555280-26-000015Section “Summary Compensation Table”. As printed: 3,974,341. Filing ↗machine: r9 · c24 · span 1465767–1465776
4Section 01, Robert PolzerDEF 14A2026-04-080001555280-26-000015Section “Summary Compensation Table”. As printed: 3,667,157. Filing ↗machine: r11 · c24 · span 1471904–1471913
5Section 01, Roxanne LaganoDEF 14A2026-04-080001555280-26-000015Section “Summary Compensation Table”. As printed: 2,825,280. Filing ↗machine: r14 · c24 · span 1480317–1480326
6Section 03, Wetteny Joseph PSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1558590–1558599
7Section 03, Wetteny Joseph RSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1555908–1555915
8Section 03, Kristin Peck PSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1548161–1548170
9Section 03, Jamie Brannan PSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1569822–1569831
10Section 03, Jamie Brannan OPTIONDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1564344–1564351
11Section 03, Jamie Brannan RSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1566814–1566821
12Section 03, Wetteny Joseph OPTIONDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1553581–1553588
13Section 03, Roxanne Lagano RSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1588590–1588597
14Section 03, Kristin Peck OPTIONDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1542310–1542319
15Section 03, Robert Polzer OPTIONDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1575208–1575215
16Section 03, Robert Polzer RSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1577499–1577506
17Section 03, Robert Polzer PSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1580180–1580189
18Section 03, Roxanne Lagano PSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1592142–1592149
19Section 03, Kristin Peck RSUDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1545015–1545024
20Section 03, Roxanne Lagano OPTIONDEF 14A2026-04-080001555280-26-000015Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 1586044–1586051
21Section 07, pay ratioDEF 14A2026-04-080001555280-26-000015Section “CEO Pay Ratio”. As printed: 236 : 1. Filing ↗machine: span 1888133–1888141
22Section 08, Michael B. McCallisterDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 500,000. Filing ↗machine: t114 · r9 · c13 · span 954793–954921
23Section 08, Frank A. D'AmelioDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 375,000. Filing ↗machine: t114 · r5 · c13 · span 943059–943187
24Section 08, Gregory NordenDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 375,000. Filing ↗machine: t114 · r10 · c13 · span 957436–957564
25Section 08, Willie M. ReedDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 375,000. Filing ↗machine: t114 · r12 · c13 · span 963587–963715
26Section 08, Louise M. ParentDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 373,750. Filing ↗machine: t114 · r11 · c15 · span 960943–961071
27Section 08, Gavin D.K. HattersleyDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 356,250. Filing ↗machine: t114 · r6 · c13 · span 945709–945837
28Section 08, Vanessa BroadhurstDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 355,000. Filing ↗machine: t114 · r4 · c15 · span 940082–940210
29Section 08, Antoinette R. LeatherberryDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 355,000. Filing ↗machine: t114 · r8 · c15 · span 951817–951945
30Section 08, Paul M. BisaroDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 350,000. Filing ↗machine: t114 · r3 · c13 · span 936949–937077
31Section 08, Sanjay KhoslaDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 350,000. Filing ↗machine: t114 · r7 · c13 · span 948676–948804
32Section 08, Mark StetterDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 316,667. Filing ↗machine: t114 · r14 · c13 · span 969198–969326
33Section 08, Robert W. ScullyDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 300,000. Filing ↗machine: t114 · r13 · c13 · span 966557–966685
34Section 08, Stephanie TileniusDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 258,333. Filing ↗machine: t114 · r15 · c13 · span 972645–972773
35Section 08, Kristin C. PeckDEF 14A2026-04-080001555280-26-000015Section “Director Compensation”. As printed: 0. Filing ↗
36Section 02, Wetteny Joseph 2026-04-10Form 42026-04-130001628280-26-024962Insider equity transaction reported since the proxy statement. Filing ↗
37Section 02, Kevin Esch 2026-04-10Form 42026-04-130001628280-26-024965Insider equity transaction reported since the proxy statement. Filing ↗
38Section 02, Keith Sarbaugh 2026-04-10Form 42026-04-130001628280-26-024961Insider equity transaction reported since the proxy statement. Filing ↗
39Section 02, Rimma Driscoll 2026-04-10Form 42026-04-130001628280-26-024963Insider equity transaction reported since the proxy statement. Filing ↗
40Section 02, Astorga Jeannette Ferran 2026-04-10Form 42026-04-130001628280-26-024967Insider equity transaction reported since the proxy statement. Filing ↗
41Section 02, Roxanne Lagano 2026-04-10Form 42026-04-130001628280-26-024968Insider equity transaction reported since the proxy statement. Filing ↗
42Section 02, Kristin C. Peck 2026-04-10Form 42026-04-130001628280-26-024964Insider equity transaction reported since the proxy statement. Filing ↗
43Section 02, Julie Fuller 2026-04-10Form 42026-04-130001628280-26-024969Insider equity transaction reported since the proxy statement. Filing ↗
44Section 02, Kevin Esch 2026-04-30Form 42026-05-010001628280-26-029358Insider equity transaction reported since the proxy statement. Filing ↗
45Section 02, Kevin Esch 2026-04-30Form 42026-05-010001628280-26-029358Insider equity transaction reported since the proxy statement. Filing ↗
46Section 02, Kevin Esch 2026-04-30Form 42026-05-010001628280-26-029358Insider equity transaction reported since the proxy statement. Filing ↗
47Section 02, Michael B. McCallister 2026-05-11Form 42026-05-120001628280-26-034291Insider equity transaction reported since the proxy statement. Filing ↗
48Section 02, Frank A. Damelio 2026-05-13Form 42026-05-130001628280-26-034643Insider equity transaction reported since the proxy statement. Filing ↗
49Section 02, Paul M. Bisaro 2026-05-13Form 42026-05-130001628280-26-034642Insider equity transaction reported since the proxy statement. Filing ↗
50Section 02, Louise M. Parent 2026-05-20Form 42026-05-210001628280-26-037351Insider equity transaction reported since the proxy statement. Filing ↗
51Section 02, Louise M. Parent 2026-05-20Form 42026-05-210001628280-26-037351Insider equity transaction reported since the proxy statement. Filing ↗
52Section 02, Louise M. Parent 2026-05-20Form 42026-05-210001628280-26-037351Insider equity transaction reported since the proxy statement. Filing ↗
53Section 02, Louise M. Parent 2026-05-20Form 42026-05-210001628280-26-037351Insider equity transaction reported since the proxy statement. Filing ↗
54Section 02, Mark Stetter 2026-05-21Form 42026-05-260001628280-26-038153Insider equity transaction reported since the proxy statement. Filing ↗
55Section 02, Mark Stetter 2026-05-21Form 42026-05-260001628280-26-038153Insider equity transaction reported since the proxy statement. Filing ↗
56Section 02, Michael B. McCallister 2026-06-10Form 42026-06-110001628280-26-042528Insider equity transaction reported since the proxy statement. Filing ↗
57Section 02, Mark Stetter 2026-06-18Form 42026-06-220001628280-26-044657Insider equity transaction reported since the proxy statement. Filing ↗
58Section 02, Wetteny Joseph 2026-07-10Form 42026-07-140001628280-26-048202Insider equity transaction reported since the proxy statement. Filing ↗
59Section 02, Roxanne Lagano 2026-07-10Form 42026-07-140001628280-26-048204Insider equity transaction reported since the proxy statement. Filing ↗
60Section 02, Keith Sarbaugh 2026-07-10Form 42026-07-140001628280-26-048210Insider equity transaction reported since the proxy statement. Filing ↗
61Section 02, Astorga Jeannette Ferran 2026-07-10Form 42026-07-140001628280-26-048203Insider equity transaction reported since the proxy statement. Filing ↗
62Section 02, Julie Fuller 2026-07-10Form 42026-07-140001628280-26-048205Insider equity transaction reported since the proxy statement. Filing ↗
63Section 02, Rimma Driscoll 2026-07-10Form 42026-07-140001628280-26-048206Insider equity transaction reported since the proxy statement. Filing ↗
64Section 02, Kevin Esch 2026-07-10Form 42026-07-140001628280-26-048207Insider equity transaction reported since the proxy statement. Filing ↗
65Section 02, Abhay U. Nayak 2026-07-10Form 42026-07-140001628280-26-048208Insider equity transaction reported since the proxy statement. Filing ↗
66Section 02, Kristin C. Peck 2026-07-10Form 42026-07-140001628280-26-048209Insider equity transaction reported since the proxy statement. Filing ↗
67Section 02, Frank A. Damelio 2026-08-07Form 42026-08-110001628280-26-055777Insider equity transaction reported since the proxy statement. Filing ↗
68Section 02, James Saccaro 2026-08-31Form 42026-09-020001628280-26-060136Insider equity transaction reported since the proxy statement. Filing ↗
69Section 02, Mark Stetter 2026-09-17Form 42026-09-180001628280-26-062776Insider equity transaction reported since the proxy statement. Filing ↗
70Section 02, Julie Fuller 2026-09-30Form 42026-10-020001628280-26-064578Insider equity transaction reported since the proxy statement. Filing ↗
71Section 02, Julie Fuller 2026-09-30Form 42026-10-020001628280-26-064578Insider equity transaction reported since the proxy statement. Filing ↗
72Section 02, Julie Fuller 2026-09-30Form 42026-10-020001628280-26-064578Insider equity transaction reported since the proxy statement. Filing ↗
73Section 02, Roxanne Lagano 2026-10-09Form 42026-10-130001628280-26-065803Insider equity transaction reported since the proxy statement. Filing ↗
74Section 02, Kristin C. Peck 2026-10-09Form 42026-10-130001628280-26-065810Insider equity transaction reported since the proxy statement. Filing ↗
75Section 02, Kevin Esch 2026-10-09Form 42026-10-130001628280-26-065809Insider equity transaction reported since the proxy statement. Filing ↗
76Section 02, Rimma Driscoll 2026-10-09Form 42026-10-130001628280-26-065808Insider equity transaction reported since the proxy statement. Filing ↗
77Section 02, Julie Fuller 2026-10-09Form 42026-10-130001628280-26-065807Insider equity transaction reported since the proxy statement. Filing ↗
78Section 02, Keith Sarbaugh 2026-10-09Form 42026-10-130001628280-26-065806Insider equity transaction reported since the proxy statement. Filing ↗
79Section 02, Astorga Jeannette Ferran 2026-10-09Form 42026-10-130001628280-26-065805Insider equity transaction reported since the proxy statement. Filing ↗
80Section 02, Abhay U. Nayak 2026-10-09Form 42026-10-130001628280-26-065804Insider equity transaction reported since the proxy statement. Filing ↗
81Section 06, 2026 voteForm 8-K2026-05-220001555280-26-000029Item 5.07 · say-on-pay result. As reported: 85.57% (votes for as printed: 306,328,992). Filing ↗
82Section 06, 2025 voteForm 8-K2025-05-220001555280-25-000213Item 5.07 · say-on-pay result. As reported: 90.47% (votes for as printed: 334,181,202). Filing ↗
83Section 06, 2024 voteForm 8-K2024-05-230001555280-24-000257Item 5.07 · say-on-pay result. As reported: 90.94% (votes for as printed: 351,133,259). Filing ↗
84Section 01 trend, Δ column (computed)Computed——Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1)
85Section 03b vehicle mix (computed)Computed——RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio
86Section 09b board cost (computed)Computed——Cash 1,375,000 + equity 3,250,000 + all other 15,000 = 4,640,000, summed across the director compensation table rows.machine: formula: Σ = 4,640,000
87Thermo Fisher Scientific Inc., Section 10b CEO totalDEF 14A2026-04-070001193125-26-144585CEO total compensation as printed in Thermo Fisher Scientific Inc.'s own proxy. As printed: 79,923,350. Filing ↗machine: span 973487–973497
88Baxter International Inc., Section 10b CEO totalDEF 14A2026-03-230001628280-26-020330CEO total compensation as printed in Baxter International Inc.'s own proxy. As printed: 29,805,182. Filing ↗machine: r4 · c30 · span 1451066–1451076
89Gilead Sciences, Inc, Section 10b CEO totalDEF 14A2026-03-200001308179-26-000106CEO total compensation as printed in Gilead Sciences, Inc's own proxy. As printed: 28,437,198. Filing ↗machine: t414 · r1 · c29 · span 989582–989592
90IQVIA Holdings Inc., Section 10b CEO totalDEF 14A2026-02-270001628280-26-012892CEO total compensation as printed in IQVIA Holdings Inc.'s own proxy. As printed: 28,128,245. Filing ↗machine: t232 · r4 · c10 · span 1613956–1613966
91Biogen Inc., Section 10b CEO totalDEF 14A2026-04-280001193125-26-187303CEO total compensation as printed in Biogen Inc.'s own proxy. As printed: 23,646,004. Filing ↗machine: r2 · c16 · span 1174380–1174391
92Boston Scientific Corporation, Section 10b CEO totalDEF 14A2026-03-180000885725-26-000025CEO total compensation as printed in Boston Scientific Corporation's own proxy. As printed: 23,532,050. Filing ↗machine: r2 · c27 · span 1249807–1249817
93Bristol-Myers Squibb Company, Section 10b CEO totalDEF 14A2026-03-250000014272-26-000006CEO total compensation as printed in Bristol-Myers Squibb Company's own proxy. As printed: 21,879,919. Filing ↗machine: t168 · r3 · c15 · span 1302160–1302170
94Stryker Corporation, Section 10b CEO totalDEF 14A2026-03-230000310764-26-000013CEO total compensation as printed in Stryker Corporation's own proxy. As printed: 21,401,495. Filing ↗machine: t101 · r2 · c7 · span 1584979–1584989
95Vertex Pharmaceuticals, Section 10b CEO totalDEF 14A2026-04-020000875320-26-000153CEO total compensation as printed in Vertex Pharmaceuticals's own proxy. As printed: 21,144,261. Filing ↗machine: r2 · c13 · span 2942799–2942809
96Intuitive Surgical Inc., Section 10b CEO totalDEF 14A2026-03-130001035267-26-000023CEO total compensation as printed in Intuitive Surgical Inc.'s own proxy. As printed: 20,997,480. Filing ↗machine: r2 · c48 · span 762289–762299
97Zoetis Inc. (subject), Section 10b CEO totalDEF 14A2026-04-080001555280-26-000015CEO total compensation as printed in Zoetis Inc.'s own proxy. As printed: 19,046,509. Filing ↗machine: r3 · c24 · span 1448788–1448798
98Edward Lifesciences Corporation, Section 10b CEO totalDEF 14A2026-03-260001099800-26-000015CEO total compensation as printed in Edward Lifesciences Corporation's own proxy. As printed: 17,454,255. Filing ↗machine: r2 · c27 · span 965441–965451
99Becton, Dickinson and Company, Section 10b CEO totalDEF 14A2025-12-180001628280-25-057846CEO total compensation as printed in Becton, Dickinson and Company's own proxy. As printed: 17,129,140. Filing ↗machine: r2 · c27 · span 1173285–1173295
100Zimmer Biomet Holdings, Inc., Section 10b CEO totalDEF 14A2026-04-010001193125-26-135661CEO total compensation as printed in Zimmer Biomet Holdings, Inc.'s own proxy. As printed: 16,106,550. Filing ↗machine: t111 · r3 · c16 · span 1895785–1895795
101Elanco Animal Health Incorporated, Section 10b CEO totalDEF 14A2026-04-080001739104-26-000016CEO total compensation as printed in Elanco Animal Health Incorporated's own proxy. As printed: 14,925,756. Filing ↗machine: r4 · c24 · span 1067844–1067854
102IDEXX Laboratories, Inc., Section 10b CEO totalDEF 14A2026-03-270000874716-26-000064CEO total compensation as printed in IDEXX Laboratories, Inc.'s own proxy. As printed: 14,580,122. Filing ↗machine: span 1576008–1576018
103Agilent Technologies, Inc., Section 10b CEO totalDEF 14A2026-02-060001193125-26-040286CEO total compensation as printed in Agilent Technologies, Inc.'s own proxy. As printed: 12,827,236. Filing ↗machine: r3 · c29 · span 1450982–1450992
104Section 10a, Gilead Sciences, Inc reciprocityDEF 14A—0001308179-26-000106Gilead Sciences, Inc's most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗
105Section 10a, Stryker Corporation reciprocityDEF 14A—0000310764-26-000013Stryker Corporation's most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗
106Section 10a, Bristol-Myers Squibb Company reciprocityDEF 14A—0000014272-26-000006Bristol-Myers Squibb Company's most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗
107Section 10a, IDEXX Laboratories, Inc. reciprocityDEF 14A—0000874716-26-000064IDEXX Laboratories, Inc. names Zoetis Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗
108Section 10a, Intuitive Surgical Inc. reciprocityDEF 14A—0001035267-26-000023Intuitive Surgical Inc.'s most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗
109Section 10a, Elanco Animal Health Incorporated reciprocityDEF 14A—0001739104-26-000016Elanco Animal Health Incorporated names Zoetis Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗
110Section 10a, Zimmer Biomet Holdings, Inc. reciprocityDEF 14A—0001193125-26-135661Zimmer Biomet Holdings, Inc.'s most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗
111Section 10a, Edward Lifesciences Corporation reciprocityDEF 14A—0001099800-26-000015Edward Lifesciences Corporation's most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗
112Section 10a, Vertex Pharmaceuticals reciprocityDEF 14A—0000875320-26-000153Vertex Pharmaceuticals's most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗
113Section 10a, Agilent Technologies, Inc. reciprocityDEF 14A—0001193125-26-040286Agilent Technologies, Inc. names Zoetis Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗
114Section 10a, Baxter International Inc. reciprocityDEF 14A—0001628280-26-020330Baxter International Inc.'s most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗
115Section 10a, IQVIA Holdings Inc. reciprocityDEF 14A—0001628280-26-012892IQVIA Holdings Inc. names Zoetis Inc. in its own disclosed peer group (read from its most recent proxy). Filing ↗
116Section 10a, Becton, Dickinson and Company reciprocityDEF 14A—0001628280-25-057846Becton, Dickinson and Company's most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗
117Section 10a, Boston Scientific Corporation reciprocityDEF 14A—0000885725-26-000025Boston Scientific Corporation's most recent proxy was read; its disclosed peer group does not include Zoetis Inc.. Filing ↗

The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.

You'll confirm on The Pay Desk's sign-up page.

Get the Zoetis Inc. Executive Compensation Report

$1,500

Buy the report - $1,500Both reports - $2,400
ZTS Peer Teardown Report